LLY — ELI LILLY & Co

—
NYSE · Health Care · Pharmaceuticals · CIK 59478 ·
Last close
$1415.55
Market Cap
$1.26T
52W High
$1475.25
52W Low
$846.81
ADV30
2,818,485
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 24,397,000,000 20,464,000,000 13,092,000,000 6,451,000,000 148,072,000,000 4,885,000,000 107,801,000,000
Jun 2026 22,974,000,000 19,706,000,000 12,457,000,000 7,095,000,000 142,283,000,000 8,950,000,000 108,404,000,000
Mar 2026 19,799,000,000 16,222,000,000 9,778,000,000 7,396,000,000 116,576,000,000 5,282,000,000 85,378,000,000
Dec 2025 19,292,000,000 15,920,300,000 8,987,400,000 6,637,700,000 112,476,000,000 7,268,000,000 85,941,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$30,644,600,000
Investing CF
$-30,413,200,000
Financing CF
$-5,141,800,000
CapEx
$-18,955,400,000
Dividends Paid
$-5,980,500,000
Buybacks
$-5,841,700,000
EPS Diluted TTM
$30.81
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$37,969,000,000
Inventory
$18,194,000,000
Receivables
$25,231,000,000
ST Investments
$121,600,000
EBIT TTM
$46,885,800,000
Pretax Income TTM
$34,769,200,000
Interest Exp TTM
$672,300,000
Analysts
29

Yahoo Snapshot (yfinance, live)

Total Revenue
$86,461,997,056
EBITDA
$46,489,001,984
Free Cash Flow
$9,343,699,968
Enterprise Value
$1,307,284,733,952
Total Cash
$4,885,000,192
Total Debt
$49,502,998,528
Shares Out
890,745,031
Trailing EPS
$30.81
Book Value
$45.19
ROE
86.0%
ROA
21.1%
Div Yield
0.49%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 65,179,000,000 29,696,000,000 20,640,000,000 112,476,000,000 85,941,000,000 26,535,000,000 16,813,000,000
Dec 2024 45,043,000,000 17,040,000,000 10,590,000,000 78,715,000,000 64,443,000,000 14,272,000,000 8,818,000,000
Dec 2023 34,124,000,000 10,325,000,000 5,240,000,000 64,006,300,000 53,142,600,000 10,771,900,000 4,240,000,000
Dec 2022 28,541,400,000 8,280,400,000 6,244,800,000 49,489,800,000 38,714,400,000 10,649,800,000 7,585,700,000

TTM Snapshot

Revenues TTM
$79,665,800,000
NetIncome TTM
$26,711,200,000
OpCashFlow TTM
—
Assets (Latest)
$142,283,000,000
Forward EPS
$49.46

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $1400.00 · spot: $1382.75 · call volume: 2,799 · put volume: 3,810
Expected Move to 2026-12-18: ±$108.00 (7.81%) — implied range $1274.75 – $1490.75 · ATM straddle on $1380.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —
AZN ASTRAZENECA PLC $282.68B $182.27 —

News headlines (Yahoo Finance, 1h cache)

Lilly Buying Spree Surpasses $32B
2026-11-18 21:13 · Yahoo
Health Canada approves Lilly's Mounjaro® (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
2026-11-18 18:00 · Yahoo
VitriVax Announces $87 Million Series C Financing to Advance Lyme Disease Vaccine Candidate into the Clinic and Expand Pipeline
2026-11-18 17:45 · Yahoo
Is Lilly Stock's Winning Streak Skill Or Luck?
2026-11-18 15:07 · Yahoo
48 ETFs Add to Lilly (LLY) Holdings on Nov. 16
2026-11-18 11:02 · Yahoo
Eli Lilly Is Up 39% in a Year. Barclays Sees Another 9%
2026-11-17 22:53 · Yahoo
Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027?
2026-11-17 21:37 · Yahoo
Third-Party Vendor Linked to Eli Lilly Is Hit by Data Breach
2026-11-17 20:02 · Yahoo
Positive Trial Results Could Be A Big Moment For Eli Lilly Stock
2026-11-17 19:11 · Yahoo
Eli Lilly inks cancer pact worth up to $5.9bn with Stipple Bio
2026-11-17 17:13 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.